Q1: Why deplete the gut microbiota in immuno-oncology studies? A: Depleting the native microbiome helps researchers eliminate background noise, allowing them to isolate and understand the causal role of specific commensal bacteria in tumor progression and the efficacy of immunotherapies.

Q2: How do you choose the right antibiotic cocktail for an animal model? A: Our experts design customized regimens based on your specific research goals and target bacterial populations. Through our specialized antibiotic modification of gut microbiota, we often use a validated combination of ampicillin, vancomycin, neomycin, and metronidazole to achieve maximum knockdown efficiency.

Q3: How is the reduction in microbial load verified during the study? A: We monitor the depletion process dynamically by analyzing fecal samples before, during, and after the antibiotic treatment. We use techniques like 16S rRNA gene sequencing and qPCR to confirm the significant reduction in microbial diversity and abundance.